Polymerase chain reaction and its potential as a pharmacokinetic tool

Clin Pharmacokinet. 1992 Nov;23(5):321-7. doi: 10.2165/00003088-199223050-00001.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Acetylation
  • Arylamine N-Acetyltransferase / genetics
  • Arylamine N-Acetyltransferase / metabolism
  • Debrisoquin / pharmacokinetics
  • Genotype
  • Humans
  • Mutation
  • Oxidation-Reduction
  • Pharmacokinetics*
  • Polymerase Chain Reaction*
  • Polymorphism, Genetic*
  • Polymorphism, Restriction Fragment Length
  • Sparteine / pharmacokinetics

Substances

  • Sparteine
  • Arylamine N-Acetyltransferase
  • Debrisoquin